Response to letter to the editor.
作者信息
Liu Kathy Y, Senn Stephen, Howard Robert
机构信息
Division of Psychiatry, University College London, London, UK.
Sheffield Centre for Health and Related Research (SCHARR), The University of Sheffield, Sheffield, UK.
出版信息
Alzheimers Dement. 2025 May;21(5):e70251. doi: 10.1002/alz.70251.
Abstract
摘要
相似文献
1
Response to letter to the editor.对编辑来信的回复。
Alzheimers Dement. 2025 May;21(5):e70251. doi: 10.1002/alz.70251.
2
Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.作者对编辑来信的回复，编辑来信：作者对编辑来信的回复：日本人类乳头瘤病毒免疫接种的安全性问题：名古屋市不良事件监测数据的分析与评估
Jpn J Nurs Sci. 2020 Jan;17(1):e12310. doi: 10.1111/jjns.12310. Epub 2019 Dec 2.
3
An article on "letter to the editor".一篇关于“致编辑的信”的文章。
J Oral Maxillofac Pathol. 2023 Apr-Jun;27(2):254-256. doi: 10.4103/jomfp.jomfp_65_23. Epub 2023 Jul 13.
4
Letter to the Editor - The implications of the professionalization of health promotion in Canada: a response to JR Graham's letter to the editor.给编辑的信——加拿大健康促进专业化的影响：对 JR Graham 给编辑的信的回应。
Health Promot Chronic Dis Prev Can. 2017 May;37(5):172-173. doi: 10.24095/hpcdp.37.5.05.
5
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0
信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
6
How to write an editorial letter?如何撰写编辑信函？
Turk J Urol. 2013 Sep;39(Suppl 1):41-3. doi: 10.5152/tud.2013.053.
7
Authors' response to a letter to the editor IJPORL-D-20-01778: Response to a Letter to the Editor.作者对致编辑的一封信（IJPORL-D-20-01778）的回复：对致编辑信件的回复
Int J Pediatr Otorhinolaryngol. 2021 Jan 28:110633. doi: 10.1016/j.ijporl.2021.110633.
8
LETter To the EditoR Standards (LETTERS): Considerations for Authors, Reviewers, and Editors.致编辑的信：标准（信件）：作者、审稿人和编辑须知
J Korean Med Sci. 2024 Sep 30;39(37):e296. doi: 10.3346/jkms.2024.39.e296.
9
Reply to Letter to the Editor: Author Response to Letter to the Editor.致编辑信件的回复：作者对致编辑信件的回应。
J Am Acad Orthop Surg. 2023 Feb 1;31(3):e133-e134. doi: 10.5435/JAAOS-D-21-00805. Epub 2021 Sep 16.
10
Letter to the Editor Re: Author's Response to Letter to the Editor.致编辑的信：关于作者对致编辑信件的回复
Arch Phys Med Rehabil. 2020 Jun;101(6):1096-1097. doi: 10.1016/j.apmr.2019.12.022. Epub 2020 Mar 7.
本文引用的文献
1
Letter to the Editor.致编辑的信。
Alzheimers Dement. 2025 May;21(5):e70250. doi: 10.1002/alz.70250.
2
Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease.在评估阿尔茨海默病治疗的临床益处时避免因果欺诈。
Alzheimers Dement. 2025 Feb;21(2):e14457. doi: 10.1002/alz.14457. Epub 2025 Jan 27.
3
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials.阿尔茨海默病临床试验中相对变化与效应大小指标的比较。
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):2-7. doi: 10.1136/jnnp-2023-331941.
Zotero 插件